Aging Drug Trials
Andrew discusses the importance of the TAME trial, comparing metformin and rapamycin for longevity. He highlights the challenges in choosing a safe and effective drug for aging-related trials, shedding light on the complexities of drug selection and public perception.In this clip
From this podcast
The Proof with Simon Hill
Can We Cure Aging?: Unpacking the Interventions | Andrew Steele, PhD
Related Questions
How does Rapamycin affect aging in the context of the episode Aging w/ Metformin, Rapamycin & More: Longevity Researcher Tells All and the clip Rejuvenating the Immune System?
How does rapamycin affect aging as discussed in the episode Aging w/ Metformin, Rapamycin & More: Longevity Researcher Tells All and the clip Boosting Vaccine Efficacy, particularly in the context of episode 270 ‒ Journal club with Andrew Huberman: metformin, power of belief, & how to read scientific papers and the clip Geroprotective Agents?
What do clinical trials say about rapamycin in relation to the episode Longevity Scientist: Fasting, Supplements & Tools for Aging Well w/ Matt Kaeberlein, PhD and the clip Rapamycin Research Insights?